Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide.
Islam MD, Islam MM, Inoue A, Yesmin S, Brindha S, Yoshizue T, Tsurui H, Kurosu T, Kuroda Y
Vaccine. 2025 May 22;56:127143. doi: 10.1016/j.vaccine.2025.127143. Epub 2025 Apr 22.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 251259 | JEV-ED3 | To express the Japanese encephalitis virus envelope protein domain III in E. coli |
| 251260 | JEV-ED3_C5I | To express the Japanese encephalitis virus envelope protein domain III with a five-isoleucine tag at the C-terminus in E. coli |